Martin Šíma

University Hospital

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Anežka Klouček

Charles University

CZECH REPUBLIC

View details

Petr Palivec

University of Chemistry and Technology

CZECH REPUBLIC

View details

Ondrej Slanar

Charles University, First Faculty of Medicine

CZECH REPUBLIC

View details

Magdalena Vagnerova

University of Chemistry and Technology

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin Šíma

Research Interests

Contact this professor

Articles (20)

Effect of Quantitative Structural Properties and Drug Formulation in Four Cannabinoids (Cannabidiol, Cannabigerol, Cannabichromene, and Cannabinol) on Their Lymphatic Transport after Enteral Administration in Rats.

Zanamivir exposure in healthy rats and rats with acute lung injury.

Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats

The acute effects of methoxphenidine on behaviour and pharmacokinetics profile in animal model

Population Pharmacokinetic Model-Based Optimization of Linezolid Dosing in Hematooncological Patients With Suspected or Proven Gram-Positive Sepsis.

Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: Results of the COL-ECMO2022 trial

Tacrolimus exposure during the three-month period following allogeneic stem cell transplantation predicts overall survival

Vancomycin loading dose individualization in a population of obese patients undergoing haemodialysis based on population pharmacokinetic model

Ivacaftor pharmacokinetics and lymphatic transport after enteral administration in rats.

Vancomycin loading dose individualization in a population of obese patients undergoing haemodialysis based on population pharmacokinetic model.

Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model

Dose Optimization and Targeting Strategies of Anti-Infective Agents

Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective.

Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients.

MIDOSTAURIN - THE FIRST TARGETED THERAPY DRUG FOR PATIENTS WITH ACUTE MYELOID LEUKAEMIA WITH FLT3 MUTATION

Better Outcome of Off-Label High-Dose Ceftazidime in Hemato-Oncological Patients with Infections Caused by Extensively Drug-Resistant <i>Pseudomonas Aeruginosa</i>.

Better Outcome of Off-Label High-Dose Ceftazidime in Hemato-Oncological Patients with Infections Caused by Extensively Drug-Resistant Pseudomonas Aeruginosa

Plasma concentrations of levobupivacaine in neonates during caudal epidural analgesia maintained over 48 hours.

Plasma concentrations of levobupivacaine in neonates during caudal epidural analgesia maintained over 48 hours

Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass.

Collaborators (4)

Anežka Klouček

Petr Palivec

Ondrej Slanar

Magdalena Vagnerova

Make your next move.